Navigation Links
Mary Ann Liebert, Inc. Provides Complimentary Online Access to Breastfeeding Medicine for the Month of August
Date:7/31/2008

NEW ROCHELLE, N.Y., July 31 /PRNewswire/ -- In Recognition of World Breastfeeding Week, Mary Ann Liebert, Inc. (http://www.liebertpub.com) will provide free online access to Breastfeeding Medicine (http://www.liebertpub.com/bfm) for the entire month of August. Breastfeeding Medicine, a MEDLINE journal, the official publication of the Academy of Breastfeeding Medicine, is an international peer-reviewed medical journal providing physicians with the evidence-based information they need to further educate themselves, their hospital staff, and patients on all aspects of breastfeeding to ensure optimal care for both mother and infant. All published issues are available free online.

"Breastfeeding has a major impact on healthcare outcomes and costs since the baby has fewer medical problems (such as ear infections, allergies, and obesity), as does the mother (such as lower incidence of breast and ovarian cancer). It gives me great pleasure to extend online access to everyone for the month of August," said Mary Ann Liebert, President and CEO of Mary Ann Liebert, Inc.

Breastfeeding Medicine publishes original scientific papers, reviews, and clinical case studies on a wide spectrum of topics in lactation medicine such as the epidemiology, physiological, and psychological benefits of breastfeeding; breastfeeding recommendations and protocols; health consequences of artificial feeding; optimal nutrition for the breastfeeding mother; breastfeeding indications and contraindications; breastfeeding the premature or sick infant; breastfeeding in the chronically ill mother; management of the breastfeeding mother on medication; and much more.

"Breastfeeding Medicine focuses on the most authoritative and up-to-date clinical information, spanning both maternal and child health," said Dr. Ruth Lawrence, Editor-in-Chief and a founding member of the Aca
'/>"/>

SOURCE Mary Ann Liebert, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Frankincense Provides Relief for Osteoarthritis
2. American Media, Inc. Provides Dial-In Information for July 30 Call With Noteholders of American Media Operations, Inc. Subsidiary
3. Study provides clues to preventing and treating cancer spread
4. Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call
5. Fat Grafting Provides Permanent, Natural Looking Results - Dr. Michael Law Explains Fat Injections as a New Trend in Facial Plastic Surgery
6. Ecumen Provides Presidential Candidates 10 Top Reasons to Discuss Long-Term Care Reform
7. Redema Ergonomic Footrest Provides Consumers with Edema Relief and Portability Benefits
8. Fragmented Los Angeles Hospital Market Provides Health Systems with Little Leverage to Negotiate Higher Reimbursement
9. Canine Cancer #1 Fear of Dog Lovers; Web Exclusive By Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners
10. Purple Dog Tag Launches; Provides Hope and Healing to Thousands of US Servicemen & Veterans
11. Combined Insurance Provides Needs Assessment Checklist to Help Consumers Evaluate Their Current Supplemental Health Insurance Coverage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NTOandCALGARY,Nov.25/PRNewswire/-SentinelleMedical...g(MRI)coilsandsoftwareandCalgaryScientificInc.,ale...troducedawebversionofAegis(TM)Breast4DAdvancedVisu...thefirsttrulyzero-footprintWebclientbasedmedicalim...b(TM)platformallowsforzero-footprintaccess-requiri...
(Date:11/25/2009)...NGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAIDS...ermineexecutiveleadershipfor2010. ,, ThenewBoar...tiesinpublicpolicy,law,finance,governmenthealthpro...rdalsocomesfromawiderangeofpersonalbackgroundsincl...vingwithHIVthemselves,andrepresentingmultipleagegr...
(Date:11/25/2009)...s have found evidence of a statistically significa...patients whose estrogen receptor (ER)-positive tum...; at serine-118 (ER-alpha S118-P), according to a ...n the Journal of the National Cancer Institute . ...istant to tamoxifen. Preclinical studies have show...
(Date:11/25/2009)...lready used to fight rheumatoid arthritis, could h... , WEDNESDAY, Nov. 25 (HealthDay News) -- A dr...nd rheumatoid arthritis now also shows some promis...diabetes. , The drug, rituximab (Rituxan), help...in, even though the disease had destroyed some of ...
(Date:11/25/2009)...tive note, CDC sees few signs of trouble with the ...ealthDay News) -- The ongoing H1N1 swine flu pande...umonias among younger patients, a U.S. health offi...se in serious pneumococcal infections around the c...al Center for Immunization and Respiratory Disease...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...fluenza epidemic has raised many questions about h...otential route is through veterinarians, who, acco...e of Public Health researchers, are at markedly in...that veterinarians played a direct role in the cur...
...EA, Minn., May 14 Hundreds of Albert Lea resident...ledged to take part in the AARP(R)/Blue Zones(R) V...ion, an unprecedented city-wide health makeover de...king behind the scenes with the AARP/Blue Zones Vi...
...less, personal computers used by cancer patients t...re and further cancer research, according to a stu...ncer Center. , "We wanted to see if patient-repor...ist at Duke University Medical Center and lead inv...
...009)Researchers at Fox Chase Cancer Center uncover...trointestinal stromal tumor (GIST) patients respon...ec). Moreover, their findings point to genes that...rew K. Godwin, PhD, at Fox Chase, presents their f...
...duction in symptoms among breast cancer patients ,...searchers have discovered the nausea-easing powers...liar with, and report that the spice helped cancer...sea on the first day of chemotherapy, and reduced ...
...mic test as a predictor of overall survival benefi... 14 Data on VeriStrat, a blood-based, proteomic t...e non-small-cell lung cancer (NSCLC), will be pres...n Society of Clinical Oncology (ASCO). Results fr...
Other Medicine News:Health News:Veterinarians at high risk for viral, bacterial infections from animals 2Health News:Veterinarians at high risk for viral, bacterial infections from animals 3Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 2Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 3Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 4Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 5Health News:Patient-centered approach to capturing data from cancer patients improves care and research 2Health News:Gene signature may predict patient response to therapy for gastrointestinal stromal tumors 2Health News:Ginger Eases Nausea From Chemo 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 3
(Date:11/25/2009)...FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicald...ydisruptivesurgicaltreatmentsforthespine,announced...r30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecall...theCompany,sproductsandwillincludecommentsfrommana...dial-innumbersare1-877-407-4018fordomesticcallersa...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...ugDelivery-USMarketTrends&Analysis http://www...y---US-Market-Trends--Analysis.html ,, TheUSin...ftherapeuticapplicationsfromthedeliveryofconventio...rapeuticdrugs.Thefutureofthetechnologyhingesontoth...
(Date:11/25/2009)...PRNewswire/-- ChemoCentryx,Inc.,announcedtodaytha...theProspectiveRandomizedOralTherapyEvaluationinCro...entswithmoderate-to-severeCrohn,sdiseasedemonstrat...ityprofile.Thestudydemonstratedevidenceofclinicale...70-pointdecreaseintheCrohn,sDiseaseActivityIndex(C...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 1Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 2Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 3Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 4Trubion Announces Positive Data From a Phase 1 2 Study of TRU 016 for the Treatment of Chronic Lymphocytic Leukemia 28CLL 29 4498 5Heart Disease Treatment Breakthrough 4495 1Heart Disease Treatment Breakthrough 4495 2Heart Disease Treatment Breakthrough 4495 3TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 1TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 2TNFerade 28TM 29 Phase III Data Presented at ASCO 4493 3
...ew released today by HHS, Agency for Healthcare Re...fit is lacking for many common ways of,treating os...y supplement,ingredients, a common surgical proced...that glucosamine and chondroitin, over-the-counter...ly because of their,purported benefits to relieve ...
...ty of America (IDSA) 45TH ..., Inc. today announced,results from two important ...Society of America (IDSA) 45th Annual Meeting addi...ytial virus (RSV). RSV is a viral,pathogen that pr...pring.,While RSV typically manifests cold-like sym...
Other Medicine Technology:Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee 2MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 2MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 3MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results 4
KA-1000 Auto Refractometer
Veris Compact™
...ecta II Glaucoma Laser System features a patented ...ts with open-angle glaucoma. It selectively target...ring intraocular pressure. The Selecta II is equip...igh-energy beam of light, which induces the same c...
Buratto Acrylic lens insertion forceps
Medicine Products: